Intake of mulberry 1-deoxynojirimycin prevents diet-induced obesity through increases in adiponectin in mice.

Abstract

In this study, the anti-obesity effect of 1-deoxynojirimycin (DNJ) was examined in the diet-induced obese mouse model. Mulberry DNJ was administered to the obese mice for 12 weeks. As a result, DNJ decreased both the visceral fat weight and adipocyte size. To determine the influence of DNJ on lipid metabolism, lipid parameters of the plasma and the liver and the activities of several molecules related to lipid metabolism in the liver were measured. DNJ activated the β-oxidation system, suppressed lipid accumulation in the liver and reduced plasma triacylglycerol. Since it was thought that the factor activated in the β-oxidation system was adiponectin, plasma adiponectin levels were measured and it was shown that plasma adiponectin was increased with DNJ. Therefore, it was suggested that DNJ promoted an increase in plasma adiponectin and activated the β-oxidation system. Overall, it was shown that DNJ prevents diet-induced obesity through an increase in adiponectin.

• Authors: Tsuyoshi Tsuduki, Ikuko Kikuchi, Toshiyuki Kimura, Kiyotaka Nakagawa, Teruo Miyazawa
• Journal: Food chemistry (Food Chem) Vol. 139 Issue 1-4 Pg. 16-23 (Aug 15 2013) ISSN: 1873-7072 [Electronic] England
• PMID: 23561072 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.

Chemical References

• Adiponectin
• Dietary Fats
• 1-Deoxynojirimycin

Topics

• 1-Deoxynojirimycin (metabolism)
• Adiponectin (blood)
• Adipose Tissue (metabolism)
• Animals
• Dietary Fats (adverse effects, metabolism)
• Humans
• Lipid Metabolism
• Liver (metabolism)
• Male
• Mice
• Mice, Inbred C57BL
• Mice, Obese
• Morus (chemistry)
• Obesity (diet therapy, metabolism, prevention & control)